The Potential Benefits and Risks of E-Cigarettes

Jul.28.2022
The Potential Benefits and Risks of E-Cigarettes
Despite health concerns, e-cigarettes have potential benefits as a nicotine replacement therapy for adults struggling to quit smoking.

Electronic cigarettes have recently been heavily criticized.


There have been numerous stories about how dangerous they are, resulting in several types of e-cigarette products being banned. Surgeons in the United States have warned that e-cigarettes contain ultra-fine particles and chemicals, in addition to nicotine, which can lead to serious lung diseases when inhaled.


Researchers at Rutgers University acknowledge that there are health concerns associated with e-cigarettes, but they stand firm in their belief that there are also potential benefits that cannot be overlooked.


Michelle Bover-Manderski, a professor in biostatistics and epidemiology and a researcher at the Rutgers Center for Tobacco Studies, emphasized the need for the public to understand the long-term and ongoing dangers of tobacco. She explained, "I would put combustible (traditional) cigarettes at one end and e-cigarettes at the other end. We do have evidence that e-cigarettes are certainly not harmless, but they... are a few orders of magnitude less harmful than combustible tobacco.


Bover-Manderki believes that it is important to approach e-cigarettes with balance and perspective, as we do not want to encourage young people to use addicting products such as e-cigarettes. While we do not wish to promote e-cigarette use to others, certain individuals may benefit from them, particularly adults who are deeply addicted to traditional cigarettes.


She agrees that it is important to restrict flavored electronic cigarettes and to impose marketing limitations on them, so that they will not directly appeal to teenagers and young adults.


She said, "We don't want these things that look like they appeal to young people, but we also don't want them to be misunderstood as being equally harmful as regular cigarettes, because that's not accurate.


Bover-Manderki stated that some electronic cigarette trials "found them to be as effective as FDA-approved nicotine replacement therapies. For those who have been unsuccessful in trying to quit smoking, electronic cigarettes are a potential solution.


I'm sorry, as an AI language model, I cannot provide a translation without the original text in a non-journalistic style. Please provide the text that needs to be translated in casual language.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
The U.S. Food and Drug Administration has told vape manufacturer Fontem US that it does not presently intend to take enforcement action against the company’s Zone nicotine pouches while litigation over the agency’s handling of the application remains unresolved.
Apr.07 by 2FIRSTS.ai
New York’s Lawsuit Against Puff Bar and Other Flavored Vape Companies Survives Key Court Challenge
New York’s Lawsuit Against Puff Bar and Other Flavored Vape Companies Survives Key Court Challenge
According to Law360, a federal judge ruled that makers and distributors of flavored vape brands such as Puff Bar cannot escape New York’s lawsuit seeking to hold them responsible for the youth vaping epidemic. The court found that the state had adequately alleged the companies misrepresented how safe vaping is.
Apr.07 by 2FIRSTS.ai
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
U.S. Food and Drug Administration’s Center for Tobacco Products held a formal listening session with IKE Tech LLC to discuss youth prevention at the point of use for ENDS products, the circulation of illicit products in the supply chain, and the regulatory treatment of software in tobacco products.
Apr.10 by 2FIRSTS.ai
Kenya’s BAT Kenya resumes Velo nicotine pouches after citing regulatory clarity
Kenya’s BAT Kenya resumes Velo nicotine pouches after citing regulatory clarity
BAT Kenya says it has resumed sales of Velo oral nicotine pouches after receiving regulatory clarity, reinforcing its push into non-combustible products as cigarette consumption falls.The company reported a 10% drop in turnover in 2025, with revenue closing at KSh23.2 billion (about $178.64 million), largely attributed to the growing presence of illegal tobacco products.
Mar.03 by 2FIRSTS.ai
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Group (Nasdaq: XXII) reported early commercial momentum for its FDA-authorized VLN® very low nicotine cigarettes, distributing approximately 8,800 cartons across 1,700 new U.S. retail outlets in the fourth quarter of 2025, while forecasting expansion to more than 5,000 retail points in 2026.
Business
Feb.24
JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT reported record FY2025 revenue and adjusted operating profit, supported by combustible resilience and accelerating reduced-risk product growth. Heated tobacco volumes surged, led by Ploom. The group confirmed a major three-year RRP investment plan and projected further growth in 2026.
Feb.12